Older age at menopause and use of hormone therapy produce increased risk of hearing loss
(The North American Menopause Society (NAMS)) It has long been suspected that menopause and the use of hormones had a direct effect on hearing. However, findings from previous studies have been conflicting, with some suggesting that hearing worsens at menopause but that there is benefit with hormone therapy (HT). Now results from the first large population study conducted to assess the association show that older age at natural menopause and the use of oral HT are each associated with a higher risk of hearing loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news

BMC study finds most transgender patients don't get surgery
Hormonal therapy may be popular for transgender patients, but gender-affirming surgery is not. The findings come from a study performed by Boston Medical Center, which opened the Center for Transgender Medicine and Surgery in 2016. The study looked at 99 transgender patients undergoing hormone therapy at BMC. Researchers noted that the data was collected in the years prior to 2015, before Massachusetts required all insurers to cover medically necessary care for gender transition — such as gender-affirming… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 4, 2017 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Age of Menopause and Fracture Risk in Postmenopausal Women Age of Menopause and Fracture Risk in Postmenopausal Women
Does the age of menopause onset alter fracture risk in healthy postmenopausal women receiving hormone therapy, calcium and vitamin D supplementation, or a combination?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

How is fracture risk in postmenopausal women affected by genetic factors and hormone therapy?
A study published online in The Journal of Clinical Endocrinology and Metabolism examines the use of menopausal hormone therapy (HT) and genetic links to fracture risk in postmenopausal women.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - April 30, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

First Guide to Second-Line Hormonal Therapy for Prostate Cancer
(MedPage Today) -- Fills void in clinical guidance (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 25, 2017 Category: Geriatrics Source Type: news

Genetics may be key to hormone therapy for bone fracture in women
A new study by the University at Buffalo found women at the highest genetic risk of bone fracture benefit the most from hormone therapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 24, 2017 Category: Consumer Health News Source Type: news

Genetics are key to hormone therapy lowering risk of broken bones in older women
Women at the highest genetic risk for fracture benefit the most from hormone therapy, according to a first-of-its-kind study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 24, 2017 Category: Science Source Type: news

Idiopathic hyperprolactinemia increases anterior pituitary hormone deficiency risk
Patients with idiopathic hyperprolactinemia have a higher risk for anterior pituitary hormone deficiency that may require hormone therapy, according to findings published inClinical Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 24, 2017 Category: Endocrinology Source Type: news

Genetics are key to hormone therapy lowering risk of broken bones in older women
(University at Buffalo) Women at the highest genetic risk for fracture benefit the most from hormone therapy, according to a first-of-its-kind study led by researchers at the University at Buffalo. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2017 Category: Biology Source Type: news

Group Offers Guidance on Treating Primary Ovarian Insufficiency with Hormone Therapy (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH The American College of Obstetricians and Gynecologists has released new recommendations on using hormone therapy to treat primary ovarian … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 24, 2017 Category: Primary Care Source Type: news

Pituitary-testis axis function may improve with GnRH
Men with hypogonadotropic hypogonadism caused by congenital combined pituitary hormone deficiency may see an increase in testosterone levels using gonadotropin-releasing hormone therapy, according to new research.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 11, 2017 Category: Endocrinology Source Type: news

' Bioidentical' Oral Alternative to Compound Hormones on Horizon'Bioidentical' Oral Alternative to Compound Hormones on Horizon
New oral fixed-dose combinations of 17- β estradiol and natural progesterone are being developed that, if approved, will offer a regulated alternative to compounded hormonal therapy for menopause symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 10, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Trial: Abiraterone acetate responses even after initial hormone therapy failure
(University of Colorado Anschutz Medical Campus) Results of a 40-person clinical trial published in JAMA Oncology show that 13 percent of prostate cancer patients deemed 'hormone refractory' did, in fact, have strong responses to treatment with the next-generation hormonal drug abiraterone acetate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2017 Category: Global & Universal Source Type: news

Hormone Therapy and Changes in Menopausal Symptoms Over Time Hormone Therapy and Changes in Menopausal Symptoms Over Time
This study compared the efficacy of two forms of menopausal hormone therapy in alleviating vasomotor symptoms, insomnia, and irritability in early postmenopausal women over a period of 4 years.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 4, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

U.S. Military Doctors Don't Feel Prepared To Care For Transgender Patients
(Reuters Health) - While the majority of U.S. military doctors surveyed at a meeting last year felt they could provide “nonjudgmental” care to people who are transgender, most said they have received little or no training on transgender care.  Nearly 90 percent of the doctors said they had not received enough training to prescribe hormones to help patients prepare for a gender transition. The prevalence of gender dysphoria in the military “seems to come as a surprise to people,” said lead author Dr. Natasha Schvey, of the Uniformed Services University of the Health Sciences in Bethesda, Marylan...
Source: Healthy Living - The Huffington Post - March 16, 2017 Category: Consumer Health News Source Type: news

Few Military Doctors Well - Trained in Transgender Care: Study
Many feel unable to prescribe cross - hormone therapy to eligible patients (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - March 14, 2017 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Reproductive Medicine, News, Source Type: news

Few Military Doctors Well-Trained in Transgender Care
Many feel unable to prescribe cross-hormone therapy to eligible patients Source: HealthDay Related MedlinePlus Pages: Gay, Lesbian, Bisexual, and Transgender Health, Veterans and Military Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 13, 2017 Category: Consumer Health News Source Type: news

The evidence base for Hormone Replacement Therapy (HRT): what can we believe?
The'facts'that most women and clinicians consider in making the decision to use, or not use, HRT are frequently wrong or incorrectly applied according to a professor. New research raises serious questions about the'facts'that have led women and their doctors to believe hormone therapy (often called HRT) is unsafe. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2017 Category: Science Source Type: news

Smoking Cessation Among Transgender Women on Hormone Therapy Smoking Cessation Among Transgender Women on Hormone Therapy
The number of transgender women who quit smoking over the course of treatment in this study highlights the potential health benefit of hormone therapy.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 8, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Study: Hormone replacement therapy may help improve women's heart health, overall survival
(Cedars-Sinai Medical Center) Hormone replacement therapy has long been controversial as studies have associated it with health benefits and risks. While some studies suggest that it lowers the risk of osteoporosis and improves some aspects of heart health, others link it to higher risk of cancer and stroke. Now, a new imaging study suggests that women using hormone replacement therapy to relieve menopause symptoms face a lower risk of death and show lower levels of atherosclerosis compared to women who do not use hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 8, 2017 Category: Cancer & Oncology Source Type: news

Soy Tied To Longer Life After Breast Cancer
(Reuters Health) - - Eating more soy may be tied to better survival odds for many women with breast cancer and may not be harmful for patients treated with hormones, a new study suggests. Previous nutrition research has linked soy to a longer life, but prior studies have also suggested soy may help tumors spread by making hormone-based cancer treatments, or endocrine therapy, less effective. For the current study, researchers examined data on 6,235 U.S. and Canadian women with breast cancer. More than half of the women were followed for at least nine years. During the course of the study, women who ate the most foods conta...
Source: Healthy Living - The Huffington Post - March 8, 2017 Category: Consumer Health News Source Type: news

Isoflavones in food associated with reduced mortality for women with some breast cancers
Higher intake of foods containing isoflavones, estrogen-like compounds primarily found in soy, is associated with reduced all-cause mortality in women with hormone-receptor-negative breast cancer and women not treated with hormone therapy as part of cancer treatment, report investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 6, 2017 Category: Science Source Type: news

Exercise and psychological treatments cut cancer fatigue
Exercise and psychological interventions more effective than drug treatments Related items fromOnMedica Anxiety and depression linked to higher cancer death risk Ten year hormonal therapy cuts breast cancer relapse Advise bowel cancer patients to take more exercise GPs should advise exercise for patients with chronic disease (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 3, 2017 Category: UK Health Source Type: news

Menopausal Hormone Therapy and Alzheimer Disease Risk Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the'critical window'hypothesis of hormone therapy after menopause.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 28, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the'critical window'hypothesis of hormone therapy after menopause.Medscape Ob/Gyn (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 28, 2017 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Hormone Therapy Prolongs PFS in Low-grade Serous Cancer Hormone Therapy Prolongs PFS in Low-grade Serous Cancer
Hormone maintenance therapy prolongs progression-free survival, if not overall survival, in low-grade serous carcinoma following surgery and chemotherapy compared with routine observation alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Natpar for Hypoparathyroidism Gets Green Light in Europe Natpar for Hypoparathyroidism Gets Green Light in Europe
The first replacement hormone therapy for chronic hypoparathyroidism that cannot be treated with standard therapy of calcium and vitamin D, a rare disease, has passed the first hurdle for approval in the EU.International Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 24, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Menopausal Hormone Therapy Tied to Fecal Incontinence Menopausal Hormone Therapy Tied to Fecal Incontinence
Data from the Nurses'Health Study suggest for the first time a modest but significantly greater risk for fecal incontinence tied to estrogen-replacement therapy.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 24, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Menopausal Hormone Therapy Tied to Fecal Incontine
nce (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 24, 2017 Category: Journals (General) Source Type: news

No Harm, No Benefit for Alzheimer's From Hormone Therapy No Harm, No Benefit for Alzheimer's From Hormone Therapy
Twenty-year data from more than 8000 women showed no significant link between postmenopausal estrogen and risk for Alzheimer's, although there was a beneficial signal for early use.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 23, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Postmenopausal hormone therapy exceeding ten years may protect from dementia
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study published inNeurology. A different perspective on the same study was included in the News Alert dated 16 February 2017.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 20, 2017 Category: Endocrinology Source Type: news

Hormone therapy at onset of menopause could protect against dementia
Long-term, estrogen-based HRT could have a protective effect against dementia in women if initiated around the onset of the menopause, research has suggested. (Source: GP Online News)
Source: GP Online News - February 17, 2017 Category: Primary Care Tags: 10.1 Women's Health Source Type: news

HRT Won't Lower Women's Alzheimer's Risk
There was some hint that long-term hormone therapy might have a benefit, but results weren't definitive (Source: WebMD Health)
Source: WebMD Health - February 16, 2017 Category: Consumer Health News Source Type: news

Postmenopausal hormone therapy exceeding ten years may protect from dementia
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study. The study explored the association between postmenopausal hormone replacement therapy, Alzheimer's disease, dementia and cognition in two nation-wide case-control studies and two longitudinal cohort studies. The largest study comprised approximately 230,000 Finnish women and the follow-up time in different studies was up to 20 years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 16, 2017 Category: Science Source Type: news

HRT Won't Lower Women's Alzheimer's Risk, Study Finds
THURSDAY, Feb. 16, 2017 -- Women who use hormone therapy after menopause may not have a lower risk of developing Alzheimer's, a new study suggests. However, there was some evidence that long-term use -- over a decade -- might be tied to a lower... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2017 Category: Journals (General) Source Type: news

Hormone therapy may not protect women from Alzheimer's disease
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later, according to a study published inNeurology.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 16, 2017 Category: Endocrinology Source Type: news

Postmenopausal hormone therapy exceeding ten years may protect from dementia
(University of Eastern Finland) Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland. The study explored the association between postmenopausal hormone replacement therapy, Alzheimer's disease, dementia and cognition in two nation-wide case-control studies and two longitudinal cohort studies. The largest study comprised approximately 230,000 Finnish women and the follow-up time in different studies was up to 20 years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 16, 2017 Category: Global & Universal Source Type: news

GPs 'failing to prescribe tamoxifen to prevent breast cancer'
Conclusion This large survey shows around half of GPs surveyed were unaware of the benefits of tamoxifen: namely, that the drug can reduce the risk of breast cancer in women with a family history of the condition. Only around a quarter of GPs surveyed were aware of the current UK guidelines. Researchers found GPs were more likely to feel comfortable carrying on a prescription initiated by hospital doctors, rather than being the one to take the decision to prescribe. This is perhaps unsurprising given that the drug is still not licensed for the primary prevention of cancer. NICE currently recommends prescribers need to ta...
Source: NHS News Feed - February 14, 2017 Category: Consumer Health News Tags: Cancer Medication Medical practice Source Type: news

Transgender Health Care in Greater Boston (2017)
Report summarizes a roundtable to identify numerous issues that affect transgender health, including gaps in coverage for gender affirming services and care such as surgery and hormone therapy. Roundtable participants also emphasized that many transgender patients experience bias and have difficulty accessing providers with expertise in LGBTQ health. (Source: HSR Information Central)
Source: HSR Information Central - February 10, 2017 Category: Global & Universal Source Type: news

Uneven Use of Hormone Therapy in Breast Cancer (CME/CE)
(MedPage Today) -- Significant variations in care for adjuvant endocrine therapy (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - February 2, 2017 Category: Endocrinology Source Type: news

Under and misuse of hormone therapy decreasing, but still high
(University of Chicago Medical Center) A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy did not get this recommended component of care, which can reduce the odds of recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 2, 2017 Category: Cancer & Oncology Source Type: news

Mayo Clinic tests vaccine to provide immune response against early breast lesion
(Mayo Clinic) Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine that they hope will replace standard therapies and prevent recurrence for some, if not all, these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2017 Category: Global & Universal Source Type: news

New treatment regimen extends life for some men with recurrent prostate cancer, study finds
(Cedars-Sinai Medical Center) Adding hormonal therapy to radiation treatment can significantly improve the average long-term survival of men with prostate cancer who have had their prostate gland removed, according to a new Cedars-Sinai study published in the Feb. 2 issue of the New England Journal of Medicine. The regimen also can reduce the frequency of spread of the cancer, the study found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2017 Category: Cancer & Oncology Source Type: news

Mayo Clinic to test vaccine designed to provide immune response against early breast lesions
JACKSONVILLE, Fla. ? Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - February 1, 2017 Category: Hospital Management Source Type: news

Jury Still Out on Treating Subclinical Hypothyroid in Pregnancy Jury Still Out on Treating Subclinical Hypothyroid in Pregnancy
Use of hormone therapy in pregnant women with subclinical hypothyroidism remains controversial thanks to lack of definitive data.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 26, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Researcher examines effect of exercise on breast cancer survivors
A new study has focused on the effects of exercise and physical activity on postmenopausal breast cancer survivors taking AIs -- hormone-therapy drugs that stop the production of estrogen. The work concludes that a combination of resistance and aerobic exercise helps mitigate the side effects of AIs and improves health outcomes in breast cancer survivors, particularly their body composition. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 18, 2017 Category: Science Source Type: news

Researcher examines effect of exercise on breast cancer survivors
(Syracuse University) Gwendolyn Thomas, assistant professor of exercise science, is the co-author of a groundbreaking article in the Obesity Journal (The Obesity Society, 2017) about the effects of exercise and physical activity on postmenopausal breast cancer survivors taking AIs -- hormone-therapy drugs that stop the production of estrogen. She contends that a combination of resistance and aerobic exercise helps mitigate the side effects of AIs and improves health outcomes in breast cancer survivors, particularly their body composition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 18, 2017 Category: Cancer & Oncology Source Type: news

What is a micropenis? Cure update claims condition CAN be treated with hormone therapy
A MICROPENIS is 2.8 inches or less when erect, or 2.5 inches when “stretched” while flaccid – and researchers say there is a cure. (Source: Daily Express - Health)
Source: Daily Express - Health - January 6, 2017 Category: Consumer Health News Source Type: news

7 Tips To Lower Diabetes Risk in Menopause During the Holidays
By now, most people have been to a holiday party or two. Lots of food, lots of eggnog and other carb laden alcoholic beverages, and lots of grazing all day long on all the boxes of candy friends and business acquaintances sent to us. It's easy to gain the five pounds most people gain during the holidays, and in the process, raise your blood sugar or glucose levels too high. That's your body letting you know you have prediabetes (higher than normal but still below diabetes levels) or diabetes, and unless you take action soon, your body won't like it. Diabetes silently sneaks up on you and if untreated, slowly weakens your ...
Source: Healthy Living - The Huffington Post - December 23, 2016 Category: Consumer Health News Source Type: news